Prosecution Insights
Last updated: November 04, 2026

UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND maintains a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The institution currently has 1 pending office action. This activity is distributed across 1 distinct examiner and 1 distinct art unit. These numbers indicate a very specific and limited prosecution phase for the institution's current filings. The data does not show a broad range of active cases across different technical divisions. This focus suggests that the institution is advancing a particular research outcome through the patent office.

The busiest examiner for the portfolio is BAUSCH, SARAE L, who is handling 1 pending office action. This examiner is responsible for 1 busiest examiner pending case, which is the only pending action for the entire portfolio. This indicates that the institution's current interaction with the patent office is concentrated on this 1 individual. The involvement of 1 distinct art unit means that the technical evaluation is being conducted by 1 specialized unit. This concentration simplifies the management of the prosecution but also places the institution's immediate success in the hands of 1 examiner. The singular nature of the 1 distinct examiner allows for a very focused legal response and consistent technical arguments.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BAUSCH, SARAE L 1 29.6% +45.2%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18374074 Biomarkers Predictive Of Atopic Dermatitis That Facilitate Prevention And/Or Treatment of the Onset Atopic Dermatitis BAUSCH, SARAE L —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18374074 Biomarkers Predictive Of Atopic Dermatitis That Facilitate Prevention And/Or Treatment of the Onset Atopic Dermatitis BAUSCH, SARAE L —

Top Art Units

Art UnitApps
1699 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18374074 Biomarkers Predictive Of Atopic Dermatitis That Facilitate Prevention And/Or Treatment of the Onset Atopic Dermatitis BAUSCH, SARAE L 1699 §101§102§112 Non-Final OA — Pending Sep 28, 2023

Managing UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND have?

UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND applications?

Sarae L Bausch has the most, with 1 of UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND's pending office actions.

What technology area are UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month